Dan Calvo

Dan Calvo is the current President & CEO at seqWell. Prior to this, they were the President/CEO of Gyros Protein Technologies AB from September 2013 to April 2021. Dan has also served as the President/CEO of Oncimmune from June 2009 to September 2013, and the President/CEO of Assay Designs from April 2007 to October 2009. Before that, they were the President/CEO of Cellomics from May 2003 to September 2005, and the VP of Sales and Marketing at PerkinElmer from September 2000 to December 2002.

Dan Calvo received an AB in Biochemistry from Princeton University. Dan then went on to earn their Master of Business Administration (MBA) from Bellarmine University in the field of Business Administration and Management, General. Finally, they received their MHS in Environmental/Environmental Health Engineering from the Johns Hopkins Bloomberg School of Public Health.

Some individuals on their team include Steve Smith - Chief Commercial Officer, Jack T. Leonard - Co-founder & CTO, and Joseph Mellor - Co-founder & Chief Scientific Officer.